These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15780118)

  • 21. Alternative dialysis strategies with icodextrin.
    Panzer SE; Teitelbaum I
    Contrib Nephrol; 2012; 178():11-15. PubMed ID: 22652709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
    Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
    Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: a meta-analysis of randomized controlled trials.
    Qi H; Xu C; Yan H; Ma J
    Perit Dial Int; 2011; 31(2):179-88. PubMed ID: 21119069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of icodextrin peritoneal dialysis solution on the peritoneal membrane in the STZ-induced diabetic rat model with partial nephrectomy.
    Nakao A; Nakao K; Takatori Y; Kojo S; Inoue J; Akagi S; Sugiyama H; Wada J; Makino H
    Nephrol Dial Transplant; 2010 May; 25(5):1479-88. PubMed ID: 19759273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of icodextrin and glucose solutions for the daytime dwell in automated peritoneal dialysis.
    Woodrow G; Stables G; Oldroyd B; Gibson J; Turney JH; Brownjohn AM
    Nephrol Dial Transplant; 1999 Jun; 14(6):1530-5. PubMed ID: 10383020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A combined crystalloid and colloid pd solution as a glucose-sparing strategy for volume control in high-transport apd patients: a prospective multicenter study.
    Freida P; Issad B; Dratwa M; Lobbedez T; Wu L; Leypoldt JK; Divino-Filho JC
    Perit Dial Int; 2009; 29(4):433-42. PubMed ID: 19602609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-Polydispersity Glucose Polymers as Osmotic Agents for Peritoneal Dialysis.
    Leypoldt JK; Hoff CM; Akonur A; Holmes CJ
    Perit Dial Int; 2015; 35(4):428-35. PubMed ID: 24584616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact on peritoneal membrane of use of icodextrin-based dialysis solution in peritoneal dialysis patients.
    Moriishi M; Kawanishi H; Tsuchiya S
    Adv Perit Dial; 2006; 22():24-8. PubMed ID: 16983933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of icodextrin in automated peritoneal dialysis on blood pressure and bioelectrical impedance analysis.
    Woodrow G; Oldroyd B; Stables G; Gibson J; Turney JH; Brownjohn AM
    Nephrol Dial Transplant; 2000 Jun; 15(6):862-6. PubMed ID: 10831642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Icodextrine peritoneal dialysis solution in clinical practice].
    Opatrná S
    Vnitr Lek; 2008 Dec; 54(12):1155-60. PubMed ID: 19140524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of initial peritoneal transport characteristics, inflammation, and high glucose exposure on prognosis for peritoneal membrane function.
    Fernández-Reyes MJ; Bajo MA; Del Peso G; Ossorio M; Díaz R; Carretero B; Selgas R
    Perit Dial Int; 2012; 32(6):636-44. PubMed ID: 22473036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significant intra- and interpatient variation in ultrafiltration achieved by icodextrin in APD patients.
    Liakopoulos V; Zarogiannis S; Eleftheriadis T; Dovas S; Stefanidis I
    Perit Dial Int; 2007; 27(1):97-8. PubMed ID: 17179521
    [No Abstract]   [Full Text] [Related]  

  • 33. Relapsing culture-negative peritonitis in peritoneal dialysis patients exposed to icodextrin solution.
    MacGinley R; Cooney K; Alexander G; Cohen S; Goldsmith DJ
    Am J Kidney Dis; 2002 Nov; 40(5):1030-5. PubMed ID: 12407649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring new evidence of the clinical benefits of icodextrin solutions.
    Davies SJ
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 2():ii47-50. PubMed ID: 16825261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. When should icodextrin be started to improve atherosclerosis in peritoneal dialysis patients?
    Hiramatsu T; Hayasaki T; Hobo A; Furuta S; Kabu K; Tonozuka Y; Iida Y
    Adv Perit Dial; 2013; 29():4-8. PubMed ID: 24344482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Icodextrin with small and short dwell enhances ultrafiltration in peritoneal dialysis patients with severe overhydration.
    Kuriyama S; Otsuka Y; Iida R; Matsumoto K; Hosoya T
    Perit Dial Int; 2006; 26(4):508-9. PubMed ID: 16881350
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of peritoneal transport properties at onset of peritoneal dialysis and longitudinal follow-up.
    Clerbaux G; Francart J; Wallemacq P; Robert A; Goffin E
    Nephrol Dial Transplant; 2006 Apr; 21(4):1032-9. PubMed ID: 16364990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peritoneal transport with icodextrin solution.
    Heimbürger O
    Contrib Nephrol; 2006; 150():97-103. PubMed ID: 16720998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Failure of icodextrin to provide adequate ultrafiltration in continuous ambulatory peritoneal dialysis patients.
    Thodis E; Passadakis P; Panagoutsos S; Marinopoulos D; Vargemezis V
    Adv Perit Dial; 1999; 15():171-4. PubMed ID: 10682096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long daytime exchange in children on continuous cycling peritoneal dialysis: preservation of drained volume because of icodextrin use.
    Michallat AC; Dheu C; Loichot C; Danner S; Fischbach M
    Adv Perit Dial; 2005; 21():195-9. PubMed ID: 16686317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.